(Q42445739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Marie-Françoise Suaud-Chagny

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Yves Claustre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Danielle De Peretti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Philippe Brun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Christiane Gueudet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Nathalie Allouard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Richard Alonso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Joëlle Lourdelet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

André Oblin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gabrielle Damoiseau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Dominique Françon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Régis Steinberg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Mireille Sevrin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Hans Schoemaker

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Pascal George

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Philippe Soubrié

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bernard Scatton

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

2064-2076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300262

6 November 2019

exact match

0 references

cites work

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Two binding sites for 3H-spiroperidol on rat striatal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Molecular cloning and expression of the gene for a human D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Cloning of the cDNA and gene for a human D2 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Characterization of an α1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Is schizophrenia a neurological disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Serotonergic anxiolytics and treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Pharmacological and molecular targets in the search for novel antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

[3H]8-OH-DPAT labels the serotonin transporter in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Molecular biology of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Fast in vivo monitoring of electrically evoked dopamine release by differential pulse amperometry with untreated carbon fibre electrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

Treatment of negative symptoms in schizophrenia with amisulpride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

Depression in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

[3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300262

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12902994%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 November 2019

1020730330

0 references

Fatcat ID

release_unjvp2c27raexiszm6ko2kyudy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/unjvp2c27raexiszm6ko2kyudy

24 November 2022

mapped directly with Wikidata item

1 reference